| 719 |
Type 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and TherapiesType 2 Diabetes Mellitus and Sarcopenia as Comorbid Chronic Diseases in Older Adults: Established and Emerging Treatments and Therapies
Jakub Mesinovic, Jackson J. Fyfe, Jason Talevski, Michael J. Wheeler, Gloria K.W. Leung, Elena S. George, Melkamu T. Hunegnaw, Costas Glavas, Paul Jansons, Robin M. Daly, David ScottJakub Mesinovic, Jackson J. Fyfe, Jason Talevski, Michael J. Wheeler, Gloria K.W. Leung, Elena S. George, Melkamu T. Hunegnaw, Costas Glavas, Paul Jansons, Robin M. Daly, David Scott
KMSID: 1516084735 Diabetes Metab J. 2023;47(6):719-742. Published online 2023 September 14 DOI: http://dx.doi.org/10.4093/dmj.2023.0112 |
|
| 743 |
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral NeuropathyPharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
Han Na Jang, Tae Jung OhHan Na Jang, Tae Jung Oh
KMSID: 1516084733 Diabetes Metab J. 2023;47(6):743-756. Published online 2023 September 6 DOI: http://dx.doi.org/10.4093/dmj.2023.0018 |
|
| 757 |
Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical PracticeImmune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice
Yun Kyung Cho, Chang Hee JungYun Kyung Cho, Chang Hee Jung
KMSID: 1516084734 Diabetes Metab J. 2023;47(6):757-766. Published online 2023 July 24 DOI: http://dx.doi.org/10.4093/dmj.2023.0072 |
|
| 767 |
Ensuring Heathy Lives with the Korea Disease Control and Prevention Agency: Partnership with the Korean Diabetes AssociationEnsuring Heathy Lives with the Korea Disease Control and Prevention Agency: Partnership with the Korean Diabetes Association
Youngmee JeeYoungmee Jee
KMSID: 1516084740 Diabetes Metab J. 2023;47(6):767-768. Published online 2023 November 24 DOI: http://dx.doi.org/10.4093/dmj.2023.0406 |
|
| 769 |
Navigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of EnavogliflozinNavigating the Future of Diabetes Treatment with New Drugs: Focusing on the Possibilities and Prospects of Enavogliflozin
Sang Youl RheeSang Youl Rhee
KMSID: 1516084738 Diabetes Metab J. 2023;47(6):769-770. Published online 2023 November 24 DOI: http://dx.doi.org/10.4093/dmj.2023.0351 |
|
| 771 |
Effects of Exercise Training and Chlorogenic Acid Supplementation on Hepatic Lipid Metabolism in Prediabetes MiceEffects of Exercise Training and Chlorogenic Acid Supplementation on Hepatic Lipid Metabolism in Prediabetes Mice
Samaneh Shirkhani, Sayyed Mohammad Marandi, Mohammad Hossein Nasr-Esfahani, Seung Kyum KimSamaneh Shirkhani, Sayyed Mohammad Marandi, Mohammad Hossein Nasr-Esfahani, Seung Kyum Kim
KMSID: 1516084727 Diabetes Metab J. 2023;47(6):771-783. Published online 2023 September 8 DOI: http://dx.doi.org/10.4093/dmj.2022.0265 |
|
| 784 |
Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 InhibitionAltered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition
Ho Gyun Lee, Il Hyeon Jung, Byong Seo Park, Hye Rim Yang, Kwang Kon Kim, Thai Hien Tu, Jung-Yong Yeh, Sewon Lee, Sunggu Yang, Byung Ju Lee, Jae Geun Kim, Il Seong Nam-GoongHo Gyun Lee, Il Hyeon Jung, Byong Seo Park, Hye Rim Yang, Kwang Kon Kim, Thai Hien Tu, Jung-Yong Yeh, Sewon Lee, Sunggu Yang, Byung Ju Lee, Jae Geun Kim, Il Seong Nam-Goong
KMSID: 1516084728 Diabetes Metab J. 2023;47(6):784-795. Published online 2023 August 23 DOI: http://dx.doi.org/10.4093/dmj.2022.0261 |
|
| 796 |
Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized TrialEfficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial
Kyung Ah Han, Yong Hyun Kim, Doo Man Kim, Byung Wan Lee, Suk Chon, Tae Seo Sohn, In Kyung Jeong, Eun-Gyoung Hong, Jang Won Son, Jae Jin Nah, Hwa Rang Song, Seong In Cho, Seung-Ah Cho, Kun Ho YoonKyung Ah Han, Yong Hyun Kim, Doo Man Kim, Byung Wan Lee, Suk Chon, Tae Seo Sohn, In Kyung Jeong, Eun-Gyoung Hong, Jang Won Son, Jae Jin Nah, Hwa Rang Song, Seong In Cho, Seung-Ah Cho, Kun Ho Yoon
KMSID: 1516084731 Diabetes Metab J. 2023;47(6):796-807. Published online 2023 February 9 DOI: http://dx.doi.org/10.4093/dmj.2022.0315 |
|
| 808 |
Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week ExtensionEfficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension
Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho YoonJun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho Yoon
KMSID: 1516084732 Diabetes Metab J. 2023;47(6):808-817. Published online 2023 September 26 DOI: http://dx.doi.org/10.4093/dmj.2022.0387 |
|
| 818 |
The Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 StudyThe Efficacy and Safety of Moderate-Intensity Rosuvastatin with Ezetimibe versus High-Intensity Rosuvastatin in High Atherosclerotic Cardiovascular Disease Risk Patients with Type 2 Diabetes Mellitus: A Randomized, Multicenter, Open, Parallel, Phase 4 Study
Jun Sung Moon, Il Rae Park, Sang Soo Kim, Hye Soon Kim, Nam Hoon Kim, Sin Gon Kim, Seung Hyun Ko, Ji Hyun Lee, Inkyu Lee, Bo Kyeong Lee, Kyu Chang WonJun Sung Moon, Il Rae Park, Sang Soo Kim, Hye Soon Kim, Nam Hoon Kim, Sin Gon Kim, Seung Hyun Ko, Ji Hyun Lee, Inkyu Lee, Bo Kyeong Lee, Kyu Chang Won
KMSID: 1516084737 Diabetes Metab J. 2023;47(6):818-825. Published online 2023 November 24 DOI: http://dx.doi.org/10.4093/dmj.2023.0171 |
|
| 826 |
Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes MellitusClinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus
Da Young Lee, Namho Kim, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Jihee Kim, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Sung-Min Park, Nan Hee KimDa Young Lee, Namho Kim, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Jihee Kim, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Sung-Min Park, Nan Hee Kim
KMSID: 1516084726 Diabetes Metab J. 2023;47(6):826-836. Published online 2023 August 24 DOI: http://dx.doi.org/10.4093/dmj.2022.0273 |
|
| 837 |
Comparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes MellitusComparison of on-Statin Lipid and Lipoprotein Levels for the Prediction of First Cardiovascular Event in Type 2 Diabetes Mellitus
Ji Yoon Kim, Jimi Choi, Sin Gon Kim, Nam Hoon KimJi Yoon Kim, Jimi Choi, Sin Gon Kim, Nam Hoon Kim
KMSID: 1516084724 Diabetes Metab J. 2023;47(6):837-845. Published online 2023 August 23 DOI: http://dx.doi.org/10.4093/dmj.2022.0217 |
|
| 846 |
Differential Impact of Obesity on the Risk of Diabetes Development in Two Age Groups: Analysis from the National Health Screening ProgramDifferential Impact of Obesity on the Risk of Diabetes Development in Two Age Groups: Analysis from the National Health Screening Program
Tae Kyung Yoo, Kyung-Do Han, Yang-Hyun Kim, Ga Eun Nam, Sang Hyun Park, Eun-Jung Rhee, Won-Young LeeTae Kyung Yoo, Kyung-Do Han, Yang-Hyun Kim, Ga Eun Nam, Sang Hyun Park, Eun-Jung Rhee, Won-Young Lee
KMSID: 1516084729 Diabetes Metab J. 2023;47(6):846-858. Published online 2023 August 23 DOI: http://dx.doi.org/10.4093/dmj.2022.0242 |
|
| 859 |
Prediabetes Progression and Regression on Objectively-Measured Physical Function: A Prospective Cohort StudyPrediabetes Progression and Regression on Objectively-Measured Physical Function: A Prospective Cohort Study
Shanhu Qiu, Yiming Zhu, Bo Xie, Wenji Chen, Duolao Wang, Xue Cai, Zilin Sun, Tongzhi WuShanhu Qiu, Yiming Zhu, Bo Xie, Wenji Chen, Duolao Wang, Xue Cai, Zilin Sun, Tongzhi Wu
KMSID: 1516084730 Diabetes Metab J. 2023;47(6):859-868. Published online 2023 August 23 DOI: http://dx.doi.org/10.4093/dmj.2022.0377 |
|
| 869 |
The Risk of Shoulder Adhesive Capsulitis in Individuals with Prediabetes and Type 2 Diabetes Mellitus: A Longitudinal Nationwide Population-Based StudyThe Risk of Shoulder Adhesive Capsulitis in Individuals with Prediabetes and Type 2 Diabetes Mellitus: A Longitudinal Nationwide Population-Based Study
Jong-Ho Kim, Bong-Seoung Kim, Kyung-do Han, Hyuk-Sang KwonJong-Ho Kim, Bong-Seoung Kim, Kyung-do Han, Hyuk-Sang Kwon
KMSID: 1516084725 Diabetes Metab J. 2023;47(6):869-878. Published online 2023 August 23 DOI: http://dx.doi.org/10.4093/dmj.2022.0275 |
|
| 879 |
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
Da Young LeeDa Young Lee
KMSID: 1516084736 Diabetes Metab J. 2023;47(6):879-881. Published online 2023 November 24 DOI: http://dx.doi.org/10.4093/dmj.2023.0328 |
|
| 882 |
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
Nikolai N. Scherbak, Robert Kruse, Thomas Nyström, Johan JendleNikolai N. Scherbak, Robert Kruse, Thomas Nyström, Johan Jendle
KMSID: 1516084739 Diabetes Metab J. 2023;47(6):882-883. Published online 2023 November 24 DOI: http://dx.doi.org/10.4093/dmj.2023.0355 |
|
